Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 2.80 +0.08 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.72 | 52 Week High | $3.64 | |||
| Open | $2.74 | 52 Week Low | $0.14 | |||
| Day High | $2.80 | P/E | N/A | |||
| Day Low | $2.60 | EPS | $0.00 | |||
| Volume | 11,971 | |||||
